tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Technical Analysis

Compare
401 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 4.52, while Phathom Pharmaceuticals’s (PHAT) share price is $4.36, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 5.24, while Phathom Pharmaceuticals’s (PHAT) share price is $4.36, making it a Sell.

Phathom Pharmaceuticals (PHAT) Pivot Points

Apr 30, 2025, 07:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.81
3.94
4.04
4.17
4.27
4.40
4.50
Fibonacci
3.94
4.02
4.08
4.17
4.25
4.31
4.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Apr 30, 2025, 07:51 PM
Period
Simple
Exponential
MA5
4.15Buy
4.20Buy
MA10
4.16Buy
4.25Buy
MA20
4.46Sell
4.52Sell
MA50
5.17Sell
5.24Sell
MA100
6.19Sell
6.58Sell
MA200
10.28Sell
9.07Sell
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 4.25, while Phathom Pharmaceuticals’s (PHAT) share price is $4.36, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 6.58, while Phathom Pharmaceuticals’s (PHAT) share price is $4.36, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $4.36 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 5.17, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $4.36 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 6.19, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $4.36 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 10.28, creating a Sell signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Apr 30, 2025, 07:51 PM
Name
Value
Implied Action
RSI (14)
44.63
Neutral
STOCH (9,6)
31.77
Neutral
STOCHRSI (14)
30.67
Neutral
MACD (12,26)
-0.37
Sell
ADX (14)
14.54
Buy
Williams %R
-57.03
Buy
CCI (14)
-35.04
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
46.80
Neutral
ROC
2.59
Buy
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 44.63, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 14.54, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is -35.04, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is 2.59, creating a Buy signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Sell.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 44.63, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is -0.37, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 4.15, which suggests PHAT is a Buy.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 4.46, which suggests PHAT is a Sell.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 5.17, which suggests PHAT is a Sell.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 10.28, which suggests PHAT is a Sell.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -57.03, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is -35.04, which suggests PHAT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis